Search

Search Results

• 

  Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

  Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

  314-322

  15-12-2015

  https://doi.org/10.4081/itjm.2015.468

  1958

  PDF: 901

  HTML: 1232

• Acute severe renal failure in a patient receiving apixaban: a case report

  Attilia Maria Pizzini, Chiara Fantoni, Stefania Zaccaroni, Mauro Silingardi

  09-04-2024

  https://doi.org/10.4081/itjm.2024.1718

  604

  PDF: 405

  HTML: 69

• Assessment and predictors of inappropriate dose of direct oral anticoagulants

  Mosaad O. Almegren

  09-01-2024

  https://doi.org/10.4081/itjm.2024.1679

  905

  pdf: 423

  HTML: 124
• 

  Apixaban

  Gianluca Airoldi, Mauro Campanini

  128-134

  07-03-2013

  https://doi.org/10.4081/itjm.2011.128

  1172

  PDF: 1856
• 

  Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

  Andrea Rubboli

  22-28

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.22

  992

  PDF: 735
• 

  Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  153-169

  23-10-2012

  https://doi.org/10.4081/itjm.2012.153

  1684

  PDF: 1986
• 

  Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

  Luca Masotti, Mauro Campanini

  1-7

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.1

  11208

  PDF: 2885

• The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

  Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

  17-02-2025

  https://doi.org/10.4081/itjm.2025.1807

  1850

  PDF: 295

  HTML: 1
• 

  The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

  Luca Masotti, Giancarlo Landini, Grazia Panigada

  48-58

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.48

  1379

  PDF: 942
• 

  New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

  Mauro Silingardi

  65-70

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.65

  1343

  PDF: 936
• 

  New oral anticoagulants: key messages for clinicians

  Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

  74-84

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.74

  1266

  PDF: 872
• 

  Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

  Giancarlo Landini, Luca Masotti

  41-47

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.41

  917

  PDF: 801

• Patent foramen ovale and stroke: a possible association with deep vein thrombosis

  Raffaele Natale, Luca Maria Capece, Sofia Donnarumma, Pasquale Madonna, Carolina Bologna, Domenico Birra, Antonietta De Sena, Marina Lugarà, Claudio De Luca, Mariavittoria Guerra, Gabriella Oliva, Fabio Granato Corigliano, Paolo Tirelli, Vincenzo Nuzzo

  29-10-2024

  https://doi.org/10.4081/itjm.2024.1801

  1415

  PDF: 541

  HTML: 155
• 

  Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  8-21

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.8

  1316

  PDF: 865

• Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

  Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

  25-11-2024

  https://doi.org/10.4081/itjm.2024.1846

  996

  PDF: 350

  SUPPLEMENTARY MATERIAL: 219

  ACKNOWLEDGMENTS: 209

  HTML: 109
• 

  A dangerous adverse event in the use of dabigatran

  Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

  250-251

  09-11-2015

  https://doi.org/10.4081/itjm.2015.629

  1604

  PDF: 897

  HTML: 254
• 

  The treatment of venous thromboembolism with new oral anticoagulants

  Davide Imberti

  29-35

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.29

  1069

  PDF: 837
• 

  Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

  Andrea Fontanella, Pierpaolo Di Micco

  59-64

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.59

  930

  PDF: 901
• 

  Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct

  Marco Masina

  171-174

  30-09-2016

  https://doi.org/10.4081/itjm.2016.720

  1414

  PDF: 864

  HTML: 635
• 

  Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

  Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

  18-03-2021

  https://doi.org/10.4081/itjm.2021.1351

  1125

  PDF: 528

  HTML: 54
• 

  Optimal duration of anticoagulant therapy in patients with venous thromboembolism

  Gualtiero Palareti

  235-244

  14-09-2018

  https://doi.org/10.4081/itjm.2018.1077

  1486

  PDF: 1757

  HTML: 260
• 

  Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

  Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

  134-140

  12-06-2014

  https://doi.org/10.4081/itjm.2014.450

  1579

  PDF: 1229

  Appendix: 568

  HTML: 622
• 

  Young FADOI and gender medicine: sex gender differences in cardiovascular disease

  Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi

  23-31

  20-03-2018

  https://doi.org/10.4081/itjm.2018.864

  2652

  PDF: 1121

  HTML: 479
• 

  Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

  Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

  125-133

  03-06-2014

  https://doi.org/10.4081/itjm.2014.504

  2109

  PDF: 1323

  Appendix: 1088

  HTML: 756
• 

  Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

  Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

  202-206

  30-09-2016

  https://doi.org/10.4081/itjm.2016.690

  1654

  PDF: 843

  HTML: 803
• 

  Cryptogenic stroke

  Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

  185-194

  30-09-2016

  https://doi.org/10.4081/itjm.2016.682

  1900

  PDF: 1098

  HTML: 585
• 

  How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

  Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

  20-11-2023

  https://doi.org/10.4081/itjm.2023.1656

  967

  PDF: 316

  HTML: 30